Gagnon Securities LLC T2 Biosystems, Inc. Transaction History

Gagnon Securities LLC

  • $474 Million
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.09 - $565.0 $450 - $2.83 Million
5,000 Added 0.66%
766,302 $87,000
Q1 2022

May 09, 2022
BUY
$0.36 - $0.57 $249 - $394
692 Added 0.09%
761,302 $399,000
Q4 2021

Feb 08, 2022
BUY
$0.46 - $0.94 $113,064 - $231,044
245,792 Added 47.74%
760,610 $393,000
Q3 2021

Nov 12, 2021
SELL
$0.86 - $1.21 $305,081 - $429,242
-354,746 Reduced 40.8%
514,818 $471,000
Q2 2021

Jul 28, 2021
BUY
$1.04 - $1.69 $286,138 - $464,974
275,133 Added 46.29%
869,564 $1.04 Million
Q1 2021

May 14, 2021
SELL
$1.32 - $3.79 $40,128 - $115,216
-30,400 Reduced 4.87%
594,431 $963,000
Q4 2020

Feb 12, 2021
BUY
$1.06 - $1.51 $159,552 - $227,286
150,521 Added 31.73%
624,831 $775,000
Q3 2020

Nov 12, 2020
SELL
$1.15 - $2.1 $51,484 - $94,014
-44,769 Reduced 8.62%
474,310 $645,000
Q1 2020

May 11, 2020
BUY
$0.28 - $1.23 $39,796 - $174,822
142,132 Added 37.71%
519,079 $337,000
Q4 2019

Feb 14, 2020
SELL
$0.96 - $2.94 $13,588 - $41,615
-14,155 Reduced 3.62%
376,947 $441,000
Q3 2019

Nov 08, 2019
BUY
$0.58 - $3.01 $140,381 - $728,531
242,037 Added 162.37%
391,102 $978,000
Q1 2019

May 13, 2019
BUY
$2.56 - $4.48 $211,468 - $370,070
82,605 Added 124.29%
149,065 $392,000
Q4 2018

Jan 18, 2019
BUY
$2.98 - $6.86 $120,752 - $277,974
40,521 Added 156.22%
66,460 $200,000
Q3 2018

Nov 13, 2018
BUY
$5.36 - $7.83 $804 - $1,174
150 Added 0.58%
25,939 $193,000
Q2 2018

Aug 09, 2018
SELL
$5.97 - $9.58 $179 - $287
-30 Reduced 0.12%
25,789 $200,000
Q1 2018

May 09, 2018
SELL
$4.21 - $7.0 $174,887 - $290,787
-41,541 Reduced 61.67%
25,819 $168,000
Q4 2017

Feb 13, 2018
SELL
$3.73 - $4.6 $100,228 - $123,606
-26,871 Reduced 28.52%
67,360 $278,000
Q3 2017

Nov 14, 2017
BUY
$3.9 - $6.78 $367,500 - $638,886
94,231
94,231 $396,000

About T2 Biosystems, Inc.

TTOO Quotes by TradingView
  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $3.38M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Gagnon Securities LLC Portfolio

Follow Gagnon Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email